Drugmakers May Need Expert to Certify Batches
India is considering a rule that would require drugmakers to appoint a designated expert who certifies each batch of medicines before it is sold. The idea comes as concerns grow about the quality of drugs made in the country. The pharmaceutical industry is worth about $60 billion, so any change would matter widely.
Context
Context: India's drug exports have faced scrutiny after past quality failures in cough syrups linked to child deaths abroad, which pushed regulators to tighten checks. Such batch testing is meant to catch problems before medicines reach patients.
Burning Potato score: 66%